General Information of the Compound
Compound ID
CP0394494
Compound Name
Milameline
    Show/Hide
Synonyms
Milameline
Milameline hydrochloride
Miramelin
Mirameline
PD-129409
RU-35926
    Show/Hide
Structure
Formula
C8H14N2O
Molecular Weight
154.213
Canonical SMILES
CO\N=C\C1=CCCN(C)C1
    Show/Hide
InChI
InChI=1S/C8H14N2O/c1-10-5-3-4-8(7-10)6-9-11-2/h4,6H,3,5,7H2,1-2H3/b9-6+
    Show/Hide
InChIKey
YMMXHEYLRHNXAB-RMKNXTFCSA-N
CAS
139886-32-1
Physicochemical Property
logP
0.8805
Rotatable Bonds
2
Heavy Atom Count
11
Polar Areas
24.83
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
11

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9571002
SID: 15321665
ChEMBL ID
CHEMBL151938
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01310, Muscarinic acetylcholine receptor M1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 21 nM
   TI
   LI
   LO
   TS
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 5623.41 nM
   TI
   LI
   LO
   TS
Protein ID: PT01198, Muscarinic acetylcholine receptor M2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 1000 nM
   TI
   LI
   LO
   TS
Protein ID: PT01516, Muscarinic acetylcholine receptor M5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 3162.28 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Milameline )
Drug Name Milameline
Company Pfizer Inc
Indication
Cognitive impairment
Discontinued in Phase 3